Company Filing History:
Years Active: 2012
Title: Thomas Wei-Ho Lee: Innovator in Pharmaceutical Compounds
Introduction
Thomas Wei-Ho Lee is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways. His work is essential for advancing treatments for various diseases.
Latest Patents
Thomas Wei-Ho Lee holds a patent for "Pyrazole compounds as CCR1 antagonists." This patent discloses compounds that block the interaction of CCR1 and its ligands. These compounds are useful for treating a variety of diseases and disorders mediated by CCR1 activity, including autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. The patent also includes pharmaceutical compositions comprising these compounds, methods for their use in treatment, and processes for preparing these compounds and their intermediates.
Career Highlights
Thomas Wei-Ho Lee is associated with Boehringer Ingelheim International GmbH, where he continues to innovate in the pharmaceutical sector. His work has led to advancements in drug development and therapeutic applications.
Collaborations
He collaborates with esteemed colleagues, including Brian Nicholas Cook and Christian Harcken, contributing to a dynamic research environment that fosters innovation.
Conclusion
Thomas Wei-Ho Lee's contributions to pharmaceutical innovations highlight the importance of targeted therapies in treating complex diseases. His work exemplifies the impact of dedicated research and collaboration in advancing medical science.